BPC 157 Banned: Key Facts on the Latest FDA Decision We have received an uptick in questions related to this substance. We felt it was best to share our policy here to bring attention to it. . OCB adheres to WADA guidelines The Pharmacology of Longevity: Peptide Edition (Part 1) Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law FDA removes Boxed Warning about risk of leg and foot amputations for the diabetes medicine canagliflozin (Invokana, Invokamet, Invokamet XR) FDA